JP Morgan Chase’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,980
Closed -$184K 7367
2022
Q4
$184K Sell
17,980
-16,310
-48% -$165K ﹤0.01% 5082
2022
Q3
$343K Sell
34,290
-208,220
-86% -$2.07M ﹤0.01% 4676
2022
Q2
$2.42M Sell
242,510
-127,560
-34% -$1.26M ﹤0.01% 3389
2022
Q1
$3.64M Buy
+370,070
New +$3.63M ﹤0.01% 3267

Other funds holding PEPL

JP Morgan Chase's PEPL Position: Q1 2023 in Review

JP Morgan Chase sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 17,980 shares — an estimated $184K sold.

JP Morgan Chase first reported a position in PEPL in Q1 2022 and held it in 4 quarters. The position peaked at $3.64M in Q1 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • JP Morgan Chase reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 17,980 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $184K.
  • JP Morgan Chase first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q1 2022 and held it in 4 quarters.
  • JP Morgan Chase's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $3.64M in Q1 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.